Oak Crest originated with the goal of providing an academic science research environment accessible to participants spanning a broad diversity of educational levels; high school to post grad. It was the vision of Dr. Marc Baum, Oak Crest’s founder, that a small, intimate research institute could be highly complementary to established large institutions of higher learning in conducting rigorous, productive, relevant science research while broadening the participation of underrepresented groups (by race, ethnicity, gender, and socio-economic standing) in science. Three years after its 1998 incorporation this vision solidified; Drs. Baum and Moss (Senior Faculty, joined the Institute in 2001) started the first research program at Oak Crest that served community college students exclusively. Since then, programs have been added, some expanded, the number of staff tripled and the facility size has grown to match. Oak Crest continues to prosper thanks to invaluable contributions by researchers, from volunteers up through senior faculty, and through the generous funding support from government, foundations, industry, and private donors.
Findings published earlier in 2015 in teh prestigious journal Antimicrobial Agents and Chemotherapy report that a novel, subdermal implant delivering potent antiretroviral (ARV) drugs developed by Oak Crest scientists shows extreme promise in stopping the spread of HIV. The report received extensive, international news coverage, including a special feature on Crown City News, a Pasadena-based news station.
Wednesday, April 27, 2016 marked the beginning of a meeting of the minds. Young minds. Curious minds. Brilliant minds all focused on one thing – stopping the spread of sexually transmitted HIV in women.
Hosted by Dr. Marc Baum, president and senior faculty at the Oak Crest Institute of Science, the three-day Annual Meeting supported by the Integrated Preclinical/Clinical Program for HIV Microbicides and Biomedical Prevention (IPCP-MBP) program brought together a team of researchers from the Centers for Disease Control and Prevention (CDC), the University of Texas Medical Branch, Johns Hopkins Medical Institutions, Scripps Research Institute, the University of California, Los Angeles and San Diego, Vanderbilt University, Miriam Hospital and Auritec Pharmaceuticals.
Attendees at this years’ event, held in Pasadena, CA, included key personnel, Project and Core Leaders and additional stakeholders who are involved in this lifesaving research. “This meeting gives us the opportunity to get together to discuss science, the challenges we are facing and to come up with creative ideas,” says Principal Investigator, Dr. Baum. “Face-to-face meetings like this are really instrumental in driving this project forward and in the success of our research.”
More information can be found here.
After nearly 12 months of intense work, monthly teleconference meetings and hundreds of emails sent back and forth across the country, team members on the National Institutes of Health (NIH) grant (1U19AI113048-01), were able to gather in person for the first time to discuss progress on this groundbreaking research project.
Hosted by Principal Investigator, Dr. Marc Baum, president of the Oak Crest Institute of Science, the first IPCP (Integrated Preclinical/Clinical Program) Annual Meeting was held July 15-17, 2015, in Pasadena, CA. The meeting brought together key personnel, Project and Core Leaders, and other stakeholders to review Year 1 activities on the grant project and to discuss activities to meet Year 2 specific aims.
“This was truly a unique event,” said Dr. Baum. “Our young scientists at Oak Crest, many of whom have not even finished their college degrees, had the chance to converse with top notch researchers from some of the most prestigious institutions in the country. They were able to discuss groundbreaking advances in drug formulations that are urgently needed to overcome inadequate disease treatment and prevention in the developing world. Where else would they have this type of amazing opportunity?” commented Dr. Baum.
More information can be found here.
2018 © oakcrest institute of science. all rights reserved.